OMEROS CORPORATION reported $20,000 in lobbying expenditures for Q2 2025, focusing on general healthcare issues, as filed under the Lobbying Disclosure Act.
OMER Hedge Fund Activity
In the latest quarter, 54 institutional investors increased their stakes in OMER, while 71 reduced theirs. Notable transactions include MARSHALL WACE, LLP, which added 599,947 shares (+1357.2%) worth approximately $4,931,564, and MORGAN STANLEY, which added 426,478 shares (+127.7%) valued around $3,505,649. Conversely, CORMORANT ASSET MANAGEMENT, LP divested 300,000 shares (-100%) valued at about $2,466,000.
